Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
In the wake of COVID-19, rising monkeypox cases pose a potential pandemic threat. While less severe than COVID-19, its increasing spread underscores the urgency of early detection and isolation to control the disease. The main difficulty in diagnosing monkeypox arises from its prolonged diagnostic process and symptoms that are similar to those of other skin diseases, making early detection and isolation challenging. To address this, the deployment of deep learning models on edge devices presents a viable solution for the rapid and accurate detection of monkeypox. However, the resource constraints of edge devices require the use of lightweight deep learning models. The limitation of these models often involves a trade-off with accuracy, which is unacceptable in the context of medical diagnostics. Therefore, the development of optimized deep learning models that are both resource-efficient for edge computing and highly accurate becomes imperative. To this end, an attention-based MobileNetV2 model for monkeypox detection, capitalizing on the inherent lightweight design of MobileNetV2 for effective deployment on edge devices, is proposed. This model, enhanced with both spatial and channel attention mechanisms, is tailored for rapid and early-stage diagnosis of monkeypox with better accuracy. We significantly improved the Monkeypox Skin Images Dataset (MSID) by incorporating a broader range of classes for similar skin diseases, thereby substantially enriching and diversifying the training dataset. This helps better distinguish monkeypox from other similar skin diseases, particularly in its early stages or when a detailed medical examination is unavailable. To ensure transparency and interpretability, we incorporated Gradient-weighted Class Activation Mapping (Grad-CAM) and Local Interpretable Model-Agnostic Explanations (LIME) to provide clear insights into the model's diagnostic reasoning. Finally, to comprehensively assess the performance of our model, we employed a range of evaluation metrics, including Cohen's Kappa, Matthews Correlation Coefficient, and Youden's J Index, alongside traditional measures like accuracy, F1-score, precision, recall, sensitivity, and specificity. The attention-based MobileNetV2 model demonstrated impressive results, outperforming the baseline models by achieving 92.28% accuracy in the extended MSID dataset, 98.19% in the original MSID dataset, and 93.33% in the Monkeypox Skin Lesion Dataset (MSLD) dataset.
In the wake of COVID-19, rising monkeypox cases pose a potential pandemic threat. While less severe than COVID-19, its increasing spread underscores the urgency of early detection and isolation to control the disease. The main difficulty in diagnosing monkeypox arises from its prolonged diagnostic process and symptoms that are similar to those of other skin diseases, making early detection and isolation challenging. To address this, the deployment of deep learning models on edge devices presents a viable solution for the rapid and accurate detection of monkeypox. However, the resource constraints of edge devices require the use of lightweight deep learning models. The limitation of these models often involves a trade-off with accuracy, which is unacceptable in the context of medical diagnostics. Therefore, the development of optimized deep learning models that are both resource-efficient for edge computing and highly accurate becomes imperative. To this end, an attention-based MobileNetV2 model for monkeypox detection, capitalizing on the inherent lightweight design of MobileNetV2 for effective deployment on edge devices, is proposed. This model, enhanced with both spatial and channel attention mechanisms, is tailored for rapid and early-stage diagnosis of monkeypox with better accuracy. We significantly improved the Monkeypox Skin Images Dataset (MSID) by incorporating a broader range of classes for similar skin diseases, thereby substantially enriching and diversifying the training dataset. This helps better distinguish monkeypox from other similar skin diseases, particularly in its early stages or when a detailed medical examination is unavailable. To ensure transparency and interpretability, we incorporated Gradient-weighted Class Activation Mapping (Grad-CAM) and Local Interpretable Model-Agnostic Explanations (LIME) to provide clear insights into the model's diagnostic reasoning. Finally, to comprehensively assess the performance of our model, we employed a range of evaluation metrics, including Cohen's Kappa, Matthews Correlation Coefficient, and Youden's J Index, alongside traditional measures like accuracy, F1-score, precision, recall, sensitivity, and specificity. The attention-based MobileNetV2 model demonstrated impressive results, outperforming the baseline models by achieving 92.28% accuracy in the extended MSID dataset, 98.19% in the original MSID dataset, and 93.33% in the Monkeypox Skin Lesion Dataset (MSLD) dataset.
A frequent cancer in male community is Prostate cancer. If it is identified in early stages, then it will be curable. This cancer is diffusing all over the world including France, USA, Swedon and Ireland etc. More than 25,400 males are affected by this cancer. This gland looks like walnut. Most of the times it grows slowly in many men, unfortunately it grows exponentially in some people. It creates blood during urination and in semen. Early-stage identification needs close analysis and complete diagnosis with medications. For this purpose, many deep learning methods are suggested. In this paper, convolution layer based deep learning model has been used. Out of this, Visual Geometry Group-16 (VGG-16) model yields accuracy of 97.74% and mobile net model gives accuracy of 86.24%. This work suggests that all the cancers can be treated with the kit of deep learning models assisted software.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.